These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34223082)

  • 1. Efficacy estimation of a combination of triple antimicrobial agents against clinical isolates of
    Asami T; Aono A; Chikamatsu K; Igarashi Y; Morishige Y; Murase Y; Yamada H; Takaki A; Mitarai S
    JAC Antimicrob Resist; 2021 Mar; 3(1):dlab004. PubMed ID: 34223082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
    J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Schulthess B; Akdoğan Kittana FN; Hömke R; Sander P
    Antimicrob Agents Chemother; 2022 May; 66(5):e0234621. PubMed ID: 35420492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in
    Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H
    Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.
    van Ingen J; Totten SE; Helstrom NK; Heifets LB; Boeree MJ; Daley CL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6324-7. PubMed ID: 23027189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in
    Richard M; Gutiérrez AV; Viljoen A; Rodriguez-Rincon D; Roquet-Baneres F; Blaise M; Everall I; Parkhill J; Floto RA; Kremer L
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Kang N; Jeon K; Kim H; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ; Jhun BW
    Chest; 2021 Aug; 160(2):436-445. PubMed ID: 33621600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
    Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
    Rimal B; Nicklas DA; Panthi CM; Lippincott CK; Belz DC; Ignatius EH; Deck DH; Serio AW; Lamichhane G
    mSphere; 2023 Apr; 8(2):e0066522. PubMed ID: 36912629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens.
    Chew KL; Octavia S; Go J; Ng S; Tang YE; Soh P; Yong J; Jureen R; Lin RTP; Yeoh SF; Teo J
    J Antimicrob Chemother; 2021 Mar; 76(4):973-978. PubMed ID: 33338230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential
    Lee J; Ammerman N; Agarwal A; Naji M; Li SY; Nuermberger E
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168614
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.
    Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.
    Obregón-Henao A; Arnett KA; Henao-Tamayo M; Massoudi L; Creissen E; Andries K; Lenaerts AJ; Ordway DJ
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6904-12. PubMed ID: 26303795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omadacycline Potentiates Clarithromycin Activity Against
    Bich Hanh BT; Quang NT; Park Y; Heo BE; Jeon S; Park JW; Jang J
    Front Pharmacol; 2021; 12():790767. PubMed ID: 34955859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.